Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IBP | OZK |
|---|---|---|
| Price | $191.11 | $46.59 |
| Change today | ▼ 0.98% | ▼ 0.25% |
| Market cap | $5.08B | $5.08B |
| Return, 3 months | -13.8% | -5.9% |
| Return, year to date | -25.4% | +4.2% |
| Return, 1 year | -19.2% | -6.3% |
| P/E (TTM) | 20.6 | 7.7 |
| P/B | 7.9 | 0.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.74% | 3.91% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 34 | 38 |
| 30-day volatility | 39.7% | 16.9% |
| Max drawdown, 1 year | -43.8% | -17.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
